List of Tables
Table 1. Pulmonary Drugs Market Trends
Table 2. Pulmonary Drugs Market Drivers & Opportunity
Table 3. Pulmonary Drugs Market Challenges
Table 4. Pulmonary Drugs Market Restraints
Table 5. Global Pulmonary Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Pulmonary Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Pulmonary Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Pulmonary Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Pulmonary Drugs
Table 10. Global Pulmonary Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Pulmonary Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Pulmonary Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Pulmonary Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Pulmonary Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Pulmonary Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Pulmonary Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Pulmonary Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Pulmonary Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Pulmonary Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Pulmonary Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Pulmonary Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Pulmonary Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Pulmonary Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Pulmonary Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Pulmonary Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Pulmonary Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Pulmonary Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Pulmonary Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Sanofi SA Basic Information List
Table 32. Sanofi SA Description and Business Overview
Table 33. Sanofi SA Pulmonary Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Pulmonary Drugs Business of Sanofi SA (2019-2024)
Table 35. Sanofi SA Recent Developments
Table 36. Meda Pharmaceuticals Basic Information List
Table 37. Meda Pharmaceuticals Description and Business Overview
Table 38. Meda Pharmaceuticals Pulmonary Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Pulmonary Drugs Business of Meda Pharmaceuticals (2019-2024)
Table 40. Meda Pharmaceuticals Recent Developments
Table 41. Circassia Pharmaceuticals Plc. Basic Information List
Table 42. Circassia Pharmaceuticals Plc. Description and Business Overview
Table 43. Circassia Pharmaceuticals Plc. Pulmonary Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Pulmonary Drugs Business of Circassia Pharmaceuticals Plc. (2019-2024)
Table 45. Circassia Pharmaceuticals Plc. Recent Developments
Table 46. AstraZeneca Plc. Basic Information List
Table 47. AstraZeneca Plc. Description and Business Overview
Table 48. AstraZeneca Plc. Pulmonary Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Pulmonary Drugs Business of AstraZeneca Plc. (2019-2024)
Table 50. AstraZeneca Plc. Recent Developments
Table 51. GlaxoSmithKline Plc. Basic Information List
Table 52. GlaxoSmithKline Plc. Description and Business Overview
Table 53. GlaxoSmithKline Plc. Pulmonary Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Pulmonary Drugs Business of GlaxoSmithKline Plc. (2019-2024)
Table 55. GlaxoSmithKline Plc. Recent Developments
Table 56. Mallinckrodt Pharmaceuticals Plc. Basic Information List
Table 57. Mallinckrodt Pharmaceuticals Plc. Description and Business Overview
Table 58. Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Pulmonary Drugs Business of Mallinckrodt Pharmaceuticals Plc. (2019-2024)
Table 60. Mallinckrodt Pharmaceuticals Plc. Recent Developments
Table 61. Cheisi Farmaceutici S.p.A Basic Information List
Table 62. Cheisi Farmaceutici S.p.A Description and Business Overview
Table 63. Cheisi Farmaceutici S.p.A Pulmonary Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Pulmonary Drugs Business of Cheisi Farmaceutici S.p.A (2019-2024)
Table 65. Cheisi Farmaceutici S.p.A Recent Developments
Table 66. Zambon Company S.p.A Basic Information List
Table 67. Zambon Company S.p.A Description and Business Overview
Table 68. Zambon Company S.p.A Pulmonary Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Pulmonary Drugs Business of Zambon Company S.p.A (2019-2024)
Table 70. Zambon Company S.p.A Recent Developments
Table 71. Alaxia SAS Basic Information List
Table 72. Alaxia SAS Description and Business Overview
Table 73. Alaxia SAS Pulmonary Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Pulmonary Drugs Business of Alaxia SAS (2019-2024)
Table 75. Alaxia SAS Recent Developments
Table 76. Merck Sharp & Dohme Limited Basic Information List
Table 77. Merck Sharp & Dohme Limited Description and Business Overview
Table 78. Merck Sharp & Dohme Limited Pulmonary Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Pulmonary Drugs Business of Merck Sharp & Dohme Limited (2019-2024)
Table 80. Merck Sharp & Dohme Limited Recent Developments
Table 81. Boehringer Ingelheim Basic Information List
Table 82. Boehringer Ingelheim Description and Business Overview
Table 83. Boehringer Ingelheim Pulmonary Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Pulmonary Drugs Business of Boehringer Ingelheim (2019-2024)
Table 85. Boehringer Ingelheim Recent Developments
Table 86. Grifols, S.A. Basic Information List
Table 87. Grifols, S.A. Description and Business Overview
Table 88. Grifols, S.A. Pulmonary Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Pulmonary Drugs Business of Grifols, S.A. (2019-2024)
Table 90. Grifols, S.A. Recent Developments
Table 91. Abbott Laboratories Basic Information List
Table 92. Abbott Laboratories Description and Business Overview
Table 93. Abbott Laboratories Pulmonary Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Pulmonary Drugs Business of Abbott Laboratories (2019-2024)
Table 95. Abbott Laboratories Recent Developments
Table 96. AbbVie Inc. Basic Information List
Table 97. AbbVie Inc. Description and Business Overview
Table 98. AbbVie Inc. Pulmonary Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Pulmonary Drugs Business of AbbVie Inc. (2019-2024)
Table 100. AbbVie Inc. Recent Developments
Table 101. Aerogen Pharma Ltd. Basic Information List
Table 102. Aerogen Pharma Ltd. Description and Business Overview
Table 103. Aerogen Pharma Ltd. Pulmonary Drugs Products, Services and Solutions
Table 104. Revenue (US$ Million) in Pulmonary Drugs Business of Aerogen Pharma Ltd. (2019-2024)
Table 105. Aerogen Pharma Ltd. Recent Developments
Table 106. Aurobindo Pharma Ltd. Basic Information List
Table 107. Aurobindo Pharma Ltd. Description and Business Overview
Table 108. Aurobindo Pharma Ltd. Pulmonary Drugs Products, Services and Solutions
Table 109. Revenue (US$ Million) in Pulmonary Drugs Business of Aurobindo Pharma Ltd. (2019-2024)
Table 110. Aurobindo Pharma Ltd. Recent Developments
Table 111. Celon Pharma SA Basic Information List
Table 112. Celon Pharma SA Description and Business Overview
Table 113. Celon Pharma SA Pulmonary Drugs Products, Services and Solutions
Table 114. Revenue (US$ Million) in Pulmonary Drugs Business of Celon Pharma SA (2019-2024)
Table 115. Celon Pharma SA Recent Developments
Table 116. Cipla Ltd. Basic Information List
Table 117. Cipla Ltd. Description and Business Overview
Table 118. Cipla Ltd. Pulmonary Drugs Products, Services and Solutions
Table 119. Revenue (US$ Million) in Pulmonary Drugs Business of Cipla Ltd. (2019-2024)
Table 120. Cipla Ltd. Recent Developments
Table 121. F. Hoffmann La Roche Ltd. Basic Information List
Table 122. F. Hoffmann La Roche Ltd. Description and Business Overview
Table 123. F. Hoffmann La Roche Ltd. Pulmonary Drugs Products, Services and Solutions
Table 124. Revenue (US$ Million) in Pulmonary Drugs Business of F. Hoffmann La Roche Ltd. (2019-2024)
Table 125. F. Hoffmann La Roche Ltd. Recent Developments
Table 126. Glenmark Pharmaceuticals Ltd. Basic Information List
Table 127. Glenmark Pharmaceuticals Ltd. Description and Business Overview
Table 128. Glenmark Pharmaceuticals Ltd. Pulmonary Drugs Products, Services and Solutions
Table 129. Revenue (US$ Million) in Pulmonary Drugs Business of Glenmark Pharmaceuticals Ltd. (2019-2024)
Table 130. Glenmark Pharmaceuticals Ltd. Recent Developments
Table 131. Lupin Ltd. Basic Information List
Table 132. Lupin Ltd. Description and Business Overview
Table 133. Lupin Ltd. Pulmonary Drugs Products, Services and Solutions
Table 134. Revenue (US$ Million) in Pulmonary Drugs Business of Lupin Ltd. (2019-2024)
Table 135. Lupin Ltd. Recent Developments
Table 136. Medisol Lifescience Pvt. Ltd. Basic Information List
Table 137. Medisol Lifescience Pvt. Ltd. Description and Business Overview
Table 138. Medisol Lifescience Pvt. Ltd. Pulmonary Drugs Products, Services and Solutions
Table 139. Revenue (US$ Million) in Pulmonary Drugs Business of Medisol Lifescience Pvt. Ltd. (2019-2024)
Table 140. Medisol Lifescience Pvt. Ltd. Recent Developments
Table 141. Novartis AG Basic Information List
Table 142. Novartis AG Description and Business Overview
Table 143. Novartis AG Pulmonary Drugs Products, Services and Solutions
Table 144. Revenue (US$ Million) in Pulmonary Drugs Business of Novartis AG (2019-2024)
Table 145. Novartis AG Recent Developments
Table 146. Sumitomo Pharma Co. Ltd. Basic Information List
Table 147. Sumitomo Pharma Co. Ltd. Description and Business Overview
Table 148. Sumitomo Pharma Co. Ltd. Pulmonary Drugs Products, Services and Solutions
Table 149. Revenue (US$ Million) in Pulmonary Drugs Business of Sumitomo Pharma Co. Ltd. (2019-2024)
Table 150. Sumitomo Pharma Co. Ltd. Recent Developments
Table 151. Teva Pharmaceutical Industries Ltd. Basic Information List
Table 152. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 153. Teva Pharmaceutical Industries Ltd. Pulmonary Drugs Products, Services and Solutions
Table 154. Revenue (US$ Million) in Pulmonary Drugs Business of Teva Pharmaceutical Industries Ltd. (2019-2024)
Table 155. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 156. Vertex Pharmaceuticals Inc. Basic Information List
Table 157. Vertex Pharmaceuticals Inc. Description and Business Overview
Table 158. Vertex Pharmaceuticals Inc. Pulmonary Drugs Products, Services and Solutions
Table 159. Revenue (US$ Million) in Pulmonary Drugs Business of Vertex Pharmaceuticals Inc. (2019-2024)
Table 160. Vertex Pharmaceuticals Inc. Recent Developments
Table 161. Wellona Pharma Basic Information List
Table 162. Wellona Pharma Description and Business Overview
Table 163. Wellona Pharma Pulmonary Drugs Products, Services and Solutions
Table 164. Revenue (US$ Million) in Pulmonary Drugs Business of Wellona Pharma (2019-2024)
Table 165. Wellona Pharma Recent Developments
Table 166. Key Raw Materials Lists
Table 167. Raw Materials Key Suppliers Lists
Table 168. Pulmonary Drugs Downstream Customers
Table 169. Pulmonary Drugs Distributors List
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
Table 173. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Pulmonary Drugs Product Picture
Figure 2. Global Pulmonary Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pulmonary Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Pulmonary Drugs Report Years Considered
Figure 5. Global Pulmonary Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Pulmonary Drugs Revenue in 2023
Figure 7. Pulmonary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Inhaled Corticosteroids Picture
Figure 9. Long Acting Beta-2 Agonists Picture
Figure 10. Antihistamines Picture
Figure 11. Vasodilators Picture
Figure 12. Others Picture
Figure 13. Global Pulmonary Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Pulmonary Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Asthma & COPD
Figure 16. Product Picture of Allergic Rhinitis
Figure 17. Product Picture of Pulmonary Arterial Hypertension
Figure 18. Product Picture of Cystic Fibrosis
Figure 19. Product Picture of Others
Figure 20. Global Pulmonary Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Pulmonary Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Pulmonary Drugs Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Pulmonary Drugs Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Pulmonary Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Pulmonary Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Pulmonary Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Pulmonary Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Pulmonary Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Pulmonary Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Pulmonary Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Pulmonary Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Pulmonary Drugs Sales Value (%), (2019-2030)
Figure 33. United States Pulmonary Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Pulmonary Drugs Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Pulmonary Drugs Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Pulmonary Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Pulmonary Drugs Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Pulmonary Drugs Sales Value by Application (%), 2023 VS 2030
Figure 39. China Pulmonary Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Pulmonary Drugs Sales Value by Type (%), 2023 VS 2030
Figure 41. China Pulmonary Drugs Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Pulmonary Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Pulmonary Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Pulmonary Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Pulmonary Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Pulmonary Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Pulmonary Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Pulmonary Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Pulmonary Drugs Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Pulmonary Drugs Sales Value by Application (%), 2023 VS 2030
Figure 51. India Pulmonary Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Pulmonary Drugs Sales Value by Type (%), 2023 VS 2030
Figure 53. India Pulmonary Drugs Sales Value by Application (%), 2023 VS 2030
Figure 54. Pulmonary Drugs Industrial Chain
Figure 55. Pulmonary Drugs Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
